Legislators and the National Multiple Sclerosis Society have launched separate efforts to investigate rising drug costs for multiple sclerosis.
According to the NMSS, MS therapies saw spike to $78,000 from $16,000 between 2004 and 2016.
Legislators and the National Multiple Sclerosis Society have launched separate efforts to investigate rising drug costs for multiple sclerosis.
According to the NMSS, MS therapies saw spike to $78,000 from $16,000 between 2004 and 2016.
Click here to read more on Gears of Biz.